Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Over-expression and mutation of a tyrosine kinase receptor FGFR4 in tumors

Over-expression and mutation of a tyrosine kinase receptor FGFR4 in tumors

US Patent 8216783 · Granted Jul 10, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GLP-1R modulating compounds2025
Tetracyclic compounds and methods for the treatment of Zika virus infection2025
GLP-1R modulating compounds2025
Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) a2025
Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) a2025
Pyrrolo[1,2-b]pyridazine derivatives2025
Cot modulators and methods of use thereof2025
Inhibitors of peptidylarginine deiminases2025
GLP-1R modulating compounds2024
GLP-1R modulating compounds2024
GLP-1R modulating compounds2024
Thiadiazole IRAK4 inhibitors2024